ESC 365 - Bleeding risk as one of major hurdles in stroke prevention therapy prescription.

ESC Premium Access

Bleeding risk as one of major hurdles in stroke prevention therapy prescription.

Session: Biomarker-based approaches for improved atrial fibrillation management

Topic: Atrial Fibrillation (AF)

Speaker: Professor C. Granger (Durham, US)

Sponsored by Roche

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Christopher B Granger

Duke University Medical Center, Durham (United States of America)

16 presentations

1 follower

2 more presentations in this session

Novel biomarker-based risk scores for better stratification of stroke and major bleeding risk in AF patients and OAC therapy optimization.

Speaker: Associate Professor Z. Hijazi (Uppsala, SE)

How do we assess anticoagulant activity in emergency situations in NOAC treated AF patients?

Speaker: Professor P. Kamphuisen (Hilversum, NL)

Access the full session

Biomarker-based approaches for improved atrial fibrillation management

Speakers: Professor C. Granger, Associate Professor Z. Hijazi, Professor P. Kamphuisen

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources